Down Syndrome Association of Toronto [ DSAT | Down Syndrome Association of Metropolitan Toronto ]

Down Syndrome Association of Ontario

Down Syndrome Association - National Capital Region

A rare malignant hematologic disease characterized by clonal proliferation of myeloid blasts, primarily involving the bone marrow, in association with congenital disorders (e.g. Fanconi anemia, dyskeratosis congenita, Bloom syndrome, Down syndrome, c

Association for the Integrated Education of Down's Syndrome Children

Tonight in Toronto, Circle 21, an organization that provides leadership to the Down syndrome community, will be bringing together dozens of support organizations from across Canada to acknowledge their contribution and hard work in helping make life better for people who have Down syndrome.

Whether it be the Canadian Association for Supported Employment, the Canadian Down Syndrome Society, or individuals in their own right, everybody would have an idea on how to improve these systems, but the consultations that you're undertaking today and will be undertaking in the future are critically important to how programs are developed.

Question No. 654 Hon. John McKay: With regard to the proposed Rouge National Urban Park (RNUP): (a) how does the RNUP legislation and strategic plan incorporate the ecological integrity, water quality and quantity, and habitat restoration goals and priorities of (i) the Provincial Greenbelt Plan, (ii) the Rouge North Management Plan Section 4.1.1.2, (iii) the 2007 Rouge River Watershed Strategy and its targeted natural heritage system, (iv) the Little Rouge Corridor Management Plan (2007), (v) the Rouge Park Natural Heritage Action Plan (2008), ...[+++] (vi) the Toronto Great Lakes Area of Concern remedial action plan for Toronto, (vii) the federal report “How Much Habitat is Enough” and the recommendation of more than 30% forest cover and 10% wetland cover per watershed, (viii) the National Parks Act, (ix) the Ontario Provincial Parks Act, (x) the draft Rouge River Watershed Fisheries Management Plan (2011), (xi) the Oak Ridges Moraine Conservation Plan, (xii) the Endangered Species Act, (xiii) other relevant provincial, municipal and federal legislation; (b) how has the government addressed the issues raised in the unanimous November 2012 City of Toronto Motion on RNUP; (c) why has the promised RNUP “Transition Advisory Committee” not been created, (i) what is the updated timetable for the creation of this committee, (ii) what individuals or entities will comprise the advisory committee, (iii) what mandate will the advisory committee be given; (d) what steps have Environment Canada, Parks Canada and the government taken to assess the water quality, biodiversity, migratory fisheries, climatic, flood and erosion control, public health and ecological service benefits of restoring the majority of the public lands in Rouge Park to forest, wetland and meadow vegetation; (e) will the federally-owned and provincially-designated Greenbelt “Natural Heritage System” and Oak Ridges Moraine lands in north Pickering be included as part of the RNUP Study Area; (f) will the “Federal ...

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major comp ...[+++]lications associated with venous angioplasty" have occurred in Canada and, if it is not possible to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...